Literature DB >> 8581169

A gene replacement strategy for engineering nisin.

Helen M Dodd1, Nikki Horn1, Catriona J Giffard2, Michael J Gasson1.   

Abstract

A lactococcal expression system was developed which allows the exclusive production of novel nisins encoded by mutated pre-nisin (nisA) genes. This system is based on a combination of a specifically constructed host strain and vectors which facilitate the genetic manipulation of the nisA gene. The wild-type chromosomal gene is effectively replaced with a variant nisA gene, by the technique of gene replacement. The recovery of full nisin immunity was employed as a means of directly selecting strains that had acquired an intact nisA gene by the gene replacement process. With this approach the other genes required for pre-nisin maturation are not affected and any alterations to DNA sequences are restricted to only those specific mutations introduced in the nisA gene. The effectiveness of the system was demonstrated by the expression of a number of variant nisA genes leading to the successful production and characterization of nisins containing the substitutions Dha5A, Dha33A, Dha5, 33A, H27K, 130W and K12L. The enhanced yields of these engineered nisin molecules, when compared to their production in a plasmid-complementation system, underlines the improvement offered by this gene replacement strategy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8581169     DOI: 10.1099/13500872-142-1-47

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  9 in total

1.  Structure-activity relationships in the peptide antibiotic nisin: role of dehydroalanine 5.

Authors:  W C Chan; H M Dodd; N Horn; K Maclean; L Y Lian; B W Bycroft; M J Gasson; G C Roberts
Journal:  Appl Environ Microbiol       Date:  1996-08       Impact factor: 4.792

2.  Enhanced production of pediocin PA-1 and coproduction of nisin and pediocin PA-1 by Lactococcus lactis.

Authors:  N Horn; M I Martínez; J M Martínez; P E Hernández; M J Gasson; J M Rodríguez; H M Dodd
Journal:  Appl Environ Microbiol       Date:  1999-10       Impact factor: 4.792

Review 3.  Biopreservation by lactic acid bacteria.

Authors:  M E Stiles
Journal:  Antonie Van Leeuwenhoek       Date:  1996-10       Impact factor: 2.271

4.  Role of transmembrane pH gradient and membrane binding in nisin pore formation.

Authors:  G N Moll; J Clark; W C Chan; B W Bycroft; G C Roberts; W N Konings; A J Driessen
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

5.  Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.

Authors:  Christiane Szekat; Ralph W Jack; Dirk Skutlarek; Harald Färber; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

6.  Discovery of a novel lantibiotic nisin O from Blautia obeum A2-162, isolated from the human gastrointestinal tract.

Authors:  Diane Hatziioanou; Cristina Gherghisan-Filip; Gerhard Saalbach; Nikki Horn; Udo Wegmann; Sylvia H Duncan; Harry J Flint; Melinda J Mayer; Arjan Narbad
Journal:  Microbiology (Reading)       Date:  2017-08-31       Impact factor: 2.777

7.  Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy.

Authors:  P Chen; J Novak; M Kirk; S Barnes; F Qi; P W Caufield
Journal:  Appl Environ Microbiol       Date:  1998-07       Impact factor: 4.792

8.  Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens.

Authors:  Des Field; Maire Begley; Paula M O'Connor; Karen M Daly; Floor Hugenholtz; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

9.  Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.

Authors:  Evelyn M Molloy; Des Field; Paula M O' Connor; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.